Epirubucin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An italian group for the study of digestive tract cancer (GISCAD) report

This publication has 19 references indexed in Scilit:

• Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group
  European Journal Of Cancer, 1994
• Epirubicin, cisplatin and intermittent continuous infusion of 5-fluorouracil in advanced gastric cancer: an effective regimen?
  European Journal Of Cancer, 1994
• Gastric Cancer: Strategies in the surgical treatment of gastric carcinoma
  Annals of Oncology, 1994
• Chemotherapy of carcinoma of the stomach
  Cancer Treatment Reviews, 1993
• A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A mid-atlantic oncology program study
  Cancer, 1991
• Continuous 5-Fluorouracil Infusion in Advanced Gastric Carcinoma
  American Journal of Clinical Oncology, 1988
• Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative group
  European Journal of Cancer and Clinical Oncology, 1985
• A phase II study of cisplatin in advanced gastric cancer
  European Journal of Cancer and Clinical Oncology, 1983
• Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer
  American Journal of Clinical Oncology, 1983
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958